Abstract
Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women who have HPV. In lower-resource settings, where Pap testing has not been sustained or widespread, new, lower-cost HPV tests may make cervical cancer screening feasible.
Original language | English (US) |
---|---|
Pages (from-to) | 377-390 |
Number of pages | 14 |
Journal | Obstetrics and Gynecology Clinics of North America |
Volume | 40 |
Issue number | 2 |
DOIs | |
State | Published - Jun 2013 |
Externally published | Yes |
Keywords
- Cervical cancer
- Cervical intraepithelial neoplasia
- Human papillomavirus (HPV)
- Low-resource settings
- Pap testing
- Screening
- Vaccination
- Visual inspection after acetic acid (VIA)
ASJC Scopus subject areas
- Obstetrics and Gynecology